Medical Device | May 20, 2026
Shaily gets regulatory nod for launch of ShailyPen Neo device technology
The product has received tentative USFDA approval, Health Canada notice of compliance, and Indian regulatory approval
The product has received tentative USFDA approval, Health Canada notice of compliance, and Indian regulatory approval
The company intends to file an IND submission by the end of this year and begin clinical studies in 2027
Collaboration with Siddhi Diagnostics combines genomics and advanced imaging capabilities to strengthen precision diagnostics in high-growth suburban markets
Combined company targets Rs. 2,500–3,000 crore revenue by 2030; new sterile and OSD plants to begin operations by August 2026
This positions its platform as a rapidly evolving engine for next-generation genetic medicine
Growth was driven by expansion across key business segments, improving efficiencies, and sustained demand across institutional and retail channels
The company reported free cash flow of Rs. 2,590 Mn for FY26
Company enters women’s personal grooming segment while strengthening pain management portfolio with herbal Ortho Oil
Funding to support clinical development, gene therapy pipeline expansion and GMP manufacturing capabilities
FY26 revenue rises to Rs. 4,359 crore as India’s leading CDMO strengthens global footprint with EU GMP certifications, UK MHRA approval and Europe supplies
Subscribe To Our Newsletter & Stay Updated
